67 related articles for article (PubMed ID: 31846521)
1. Metastases to the ovary arising from endometrial, cervical and fallopian tube cancer: recent advances.
Casey L; Singh N
Histopathology; 2020 Jan; 76(1):37-51. PubMed ID: 31846521
[TBL] [Abstract][Full Text] [Related]
2. Pattern A endocervical adenocarcinomas with ovarian metastasis are indolent and molecularly distinct from destructively invasive adenocarcinomas.
Neil AJ; Li YY; Hakam A; Nucci MR; Parra-Herran C
Histopathology; 2024 Jan; 84(2):369-380. PubMed ID: 37920148
[TBL] [Abstract][Full Text] [Related]
3. Guidelines to Aid in the Distinction of Endometrial and Endocervical Carcinomas, and the Distinction of Independent Primary Carcinomas of the Endometrium and Adnexa From Metastatic Spread Between These and Other Sites.
Stewart CJR; Crum CP; McCluggage WG; Park KJ; Rutgers JK; Oliva E; Malpica A; Parkash V; Matias-Guiu X; Ronnett BM
Int J Gynecol Pathol; 2019 Jan; 38 Suppl 1(Iss 1 Suppl 1):S75-S92. PubMed ID: 30550485
[TBL] [Abstract][Full Text] [Related]
4. Case report: Metastatic ovarian mucinous carcinoma to the breast: diagnostic challenges and pitfalls.
Laokulrath N; Lim SK; Lim HY; Gudi M; Tan PH
Front Oncol; 2024; 14():1364011. PubMed ID: 38562166
[TBL] [Abstract][Full Text] [Related]
5. Survival from ovarian and endometrial cancer.
Chien P
BJOG; 2023 Dec; 130(13):1561-1562. PubMed ID: 37919043
[No Abstract] [Full Text] [Related]
6. Incorporation of molecular characteristics into endometrial cancer management.
Vermij L; Smit V; Nout R; Bosse T
Histopathology; 2020 Jan; 76(1):52-63. PubMed ID: 31846532
[TBL] [Abstract][Full Text] [Related]
7. Cervical adenocarcinoma: integration of HPV status, pattern of invasion, morphology and molecular markers into classification.
Park KJ
Histopathology; 2020 Jan; 76(1):112-127. PubMed ID: 31846527
[TBL] [Abstract][Full Text] [Related]
8. Molecular profiling identifies synchronous endometrial and ovarian cancers as metastatic endometrial cancer with favorable clinical outcome.
Reijnen C; Küsters-Vandevelde HVN; Ligtenberg MJL; Bulten J; Oosterwegel M; Snijders MPLM; Sweegers S; de Hullu JA; Vos MC; van der Wurff AAM; van Altena AM; Eijkelenboom A; Pijnenborg JMA
Int J Cancer; 2020 Jul; 147(2):478-489. PubMed ID: 32022266
[TBL] [Abstract][Full Text] [Related]
9. Molecular and biological profile may discriminate between synchronous or metachronous endometrial and ovarian cancer.
Iacobelli V; Zannoni GF; Gui B; Fagotti A; Scambia G; Fanfani F
Int J Gynecol Cancer; 2020 Jul; 30(7):1071-1076. PubMed ID: 32522776
[No Abstract] [Full Text] [Related]
10. An integrated molecular profile of endometrioid ovarian cancer.
Pierson WE; Peters PN; Chang MT; Chen LM; Quigley DA; Ashworth A; Chapman JS
Gynecol Oncol; 2020 Apr; 157(1):55-61. PubMed ID: 32139151
[TBL] [Abstract][Full Text] [Related]
11. A phase 3 randomized, open-label, multicenter trial for safety and efficacy of combined trabectedin and pegylated liposomal doxorubicin therapy for recurrent ovarian cancer.
Monk BJ; Herzog TJ; Wang G; Triantos S; Maul S; Knoblauch R; McGowan T; Shalaby WSW; Coleman RL
Gynecol Oncol; 2020 Mar; 156(3):535-544. PubMed ID: 31924332
[TBL] [Abstract][Full Text] [Related]
12. High homogeneity of MMR deficiency in ovarian cancer.
Fraune C; Rosebrock J; Simon R; Hube-Magg C; Makrypidi-Fraune G; Kluth M; Büscheck F; Höflmayer D; Schmalfeldt B; Müller V; Wölber L; Witzel I; Paluchowski P; Wilke C; Heilenkötter U; von Leffern I; Clauditz TS; Wilczak W; Sauter G; Steurer S; Burandt E
Gynecol Oncol; 2020 Mar; 156(3):669-675. PubMed ID: 31924330
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic options for mucinous ovarian carcinoma.
Gorringe KL; Cheasley D; Wakefield MJ; Ryland GL; Allan PE; Alsop K; Amarasinghe KC; Ananda S; Bowtell DDL; Christie M; Chiew YE; Churchman M; DeFazio A; Fereday S; Gilks CB; Gourley C; Hadley AM; Hendley J; Hunter SM; Kaufmann SH; Kennedy CJ; Köbel M; Le Page C; Li J; Lupat R; McNally OM; McAlpine JN; Pyman J; Rowley SM; Salazar C; Saunders H; Semple T; Stephens AN; Thio N; Torres MC; Traficante N; Zethoven M; Antill YC; Campbell IG; Scott CL
Gynecol Oncol; 2020 Mar; 156(3):552-560. PubMed ID: 31902686
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous germline and somatic sequencing in ovarian carcinoma: mutation rate and impact on clinical decision-making.
Jorge S; McFaddin AS; Doll KM; Pennington KP; Norquist BM; Bennett RL; Pritchard CC; Swisher EM
Gynecol Oncol; 2020 Mar; 156(3):517-522. PubMed ID: 31883735
[TBL] [Abstract][Full Text] [Related]
15. Immune checkpoint expression, microsatellite instability, and mutational burden: Identifying immune biomarker phenotypes in uterine cancer.
Jones NL; Xiu J; Rocconi RP; Herzog TJ; Winer IS
Gynecol Oncol; 2020 Feb; 156(2):393-399. PubMed ID: 31882243
[TBL] [Abstract][Full Text] [Related]
16. The pregnancy and oncology outcome of fertility-sparing management for synchronous primary neoplasm of endometrium and ovary.
Gama Q; Luo S; Wu P; Wang L; Liu S; Zhang H; Sun L; Wang Y; Yu M; Chen X; Shan W; Luo X
J Ovarian Res; 2023 Dec; 16(1):235. PubMed ID: 38062462
[TBL] [Abstract][Full Text] [Related]
17. Molecular Classification of Endometrial Cancer and the 2023 FIGO Staging: Exploring the Challenges and Opportunities for Pathologists.
Zheng W
Cancers (Basel); 2023 Aug; 15(16):. PubMed ID: 37627129
[TBL] [Abstract][Full Text] [Related]
18. Isolated tubal metastasis from an incidental HPV-associated endocervical adenocarcinoma presented as an adnexal mass: A case report.
Aljhdali H; Balega J; Williams A; Ganesan R
Case Rep Womens Health; 2023 Sep; 39():e00532. PubMed ID: 37588989
[TBL] [Abstract][Full Text] [Related]
19. Recent Advances in Cervical Cancer Management: A Review on Novel Prognostic Factors in Primary and Recurrent Tumors.
Santoro A; Inzani F; Angelico G; Arciuolo D; Bragantini E; Travaglino A; Valente M; D'Alessandris N; Scaglione G; Sfregola S; Piermattei A; Cianfrini F; Roberti P; Zannoni GF
Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831480
[TBL] [Abstract][Full Text] [Related]
20. Curious Case of Superfitial Spreading Cervical Squamocellular Carcinoma with Adnexal Involvement.
Dokić M; Milenković S; Jovanović L; Milošević B; Andrić L; Šaponjski D; Kesić V
Medicina (Kaunas); 2022 Nov; 58(11):. PubMed ID: 36422194
[No Abstract] [Full Text] [Related]
[Next] [New Search]
